Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion

Oncogene

Volumn 21, Issue 52, 2002, Pages 8011-8019

  Lakka, Sajani S ^a   Rajan, Mannari ^b   Gondi, Christopher ^a   Yanamandra, Niranjan ^a   Chandrasekar, Nirmala ^a   Jasti, Sushma L ^b   Adachi, Yoshiaki ^c   Siddique, Khawar ^a   Gujrati, Meena ^a   Olivero, William ^a   Dinh, Dzung H ^a   Kouraklis, Gregory ^d   Kyritsis, Athanassios P ^e   Rao, Jasti S ^a,f  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e UNIVERSITY OF IOANNINA   (Greece)

^f UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Adenovirus; Antisense; ECM; Glioma; MMP 9; MT MMP

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; GELATINASE B; MATRIGEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CANCER REGRESSION; CELL MIGRATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA SEQUENCE; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; GENE CONSTRUCT; GENE TARGETING; GENE THERAPY; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPHEROID CELL; TUMOR GROWTH;

ADENOVIRIDAE; ANIMALS; BASE SEQUENCE; BRAIN NEOPLASMS; CELL DIVISION; DNA PRIMERS; GLIOMA; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASM INVASIVENESS; RATS; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; MUS MUSCULUS;

EID: 18744377966     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205894     Document Type: Article

References (53)

1. Arndt GM and Rank GH. (1997). Genome, 40, 785-797.
2. Aguirre-Ghiso JA, Liu D, Mignatti A, Kovalski K and Ossowski L. (2001). Mol. Biol. Cell, 12, 863-879.
3. Adachi Y, Lakka SS, Chandrasekar N, Yanamandra N, Gondi CS, Mohanam S, Dinh DH, Olivero WC, Gujrati M, Tamiya T, Ohmoto T, Kouraklis G, Aggarwal B and Rao JS. (2001). J. Biol. Chem., 276, 47171-47177.
4. Baker AH, Zaltsman AB, George SJ and Newby AC. (1998). J. Clin. Invest., 101, 1478-1487.
5. Baxter AD, Bird JB, Bannister RBRMDT, Watson RW, Owen DA and Montana JHJaJRC. (2000). Matrix Metalloproteinase Inhibitors in Cancer Therapy, Clendeninn NJ and Appelt K. (ed.). Totowa, NJ: Humana Press, Inc., pp. 93-221.
6. Brown PD. (1999). APMIS, 107, 174-180.
7. Brown PD. (2000). Expert. Opin. Investig. Drugs, 9, 2167-2177.
8. Chambers AF and Matrisian LM. (1997). J. Natl. Cancer Inst., 89, 1260-1270.
9. Chintala SK, Sawaya R, Gokaslan ZL, Fuller G and Rao JS. (1996a). Cancer Lett., 101, 107-114.
10. Chintala SK, Sawaya R, Gokaslan ZL and Rao JS. (1996b). Cancer Lett., 102, 57-63.
11. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He CS, Bauer EA and Goldberg GI. (1988). J. Biol. Chem., 263, 6579-6587.
12. Crabbe T, O'Connell JP, Smith BJ and Docherty AJ. (1994). Biochemistry, 33, 14419- 14425.
13. Davies B, Brown PD, East N, Crimmin MJ and Balkwill FR. (1993a). Cancer Res., 53, 2087-2091.
14. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A and Balkwill F. (1993b). Cancer Res., 53, 5365-5369.
15. Dubois B, Masure S, Hurtenbach U, Paemen L, Heremans H, van den OJ, Sciot R, Meinhardt T, Hammerling G, Opdenakker G and Arnold B. (1999). J. Clin. Invest., 104, 1507-1515.
16. Eberhardt W, Huwiler A, Beck KF, Walpen S and Pfeilschifter J. (2000). J. Immunol., 165, 5788-5797.
17. Folkman J. (1999). Nat. Biotechnol., 17, 749.
18. Forsyth PA, Laing TD, Gibson AW, Rewcastle NB, Brasher P, Sutherland G, Johnston RN and Edwards DR. (1998). J. Neurooncol., 36, 21-29.
19. Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, Khoury G and Liotta LA. (1987). Cancer Res., 47, 1523-1528.
20. Go Y, Chintala SK, Mohanam S, Gokaslan Z, Venkaiah B, Bjerkvig R, Oka K, Nicolson GL, Sawaya R and Rao JS. (1997). Clin. Exp. Metast., 15, 440-446.
21. Gomez DE, Alonso DF, Yoshiji H and Thorgeirsson UP. (1997). Eur. J. Cell. Biol., 74, 111-122.
22. Graham FL and Prevec L. (1991). Methods in Molecular Biology. Murray EJ (ed.). Clifton, NJ: The Humana Press, pp. 109-127.
23. Houde M, de Bruyne G, Bracke M, Ingelman-Sundberg M, Skoglund G, Masure S, van Damme J and Opdenakker G. (1993). Int. J. Cancer, 53, 395-400.
24. Hua J and Muschel RJ. (1996). Cancer Res., 56, 5279-5284.
25. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N and Okada Y. (1995). J. Biol. Chem., 270, 6691-6697.
26. Jones JL, Glynn P and Walker RA. (1999). J. Pathol., 189, 161-168.
27. Kahari VM and Saarialho-Kere U. (1999). Ann. Med., 31, 34-45.
28. Kin Y, Chintala SK, Go Y, Sawaya R, Mohanam S, Kyritsis AP and Rao JS. (2000). Int. J. Oncol., 17, 61-65.
29. Kondraganti S, Mohanam S, Chintala SK, Kin Y, Jasti SL, Nirmala C, Lakka SS, Adachi Y, Kyritsis AP, Ali-Osman F, Sawaya R, Fuller GN and Rao JS. (2000). Cancer Res., 60, 6851-6855.
30. Konduri SD, Tasiou A, Chandrasekar N, Nicolson GL and Rao JS. (2000). Clin. Exp. Metast., 18, 303-308.
31. Koochekpour S, Merzak A and Pilkington GJ. (1995). Neurosci. Lett., 186, 53-56.
32. Lakka SS, Jasti SL, Kyritsis AP, Yung WK, Ali-Osman F, Nicolson GL and Rao JS. (2000). Clin. Exp. Metast., 18, 245-252.
33. Liotta LA, Steeg PS and Stetler-Stevenson WG. (1991). Cell, 64, 327-336.
34. Lozonschi L, Sunamura M, Kobari M, Egawa S, Ding L and Matsuno S. (1999). Cancer Res., 59, 1252-1258.
35. Mohan PM, Lakka SS, Mohanam S, Kin Y, Sawaya R, Kyritsis AP, Nicolson GL and Rao JS. (1999). Clin. Exp. Metast., 17, 617-621.
36. Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Saro H, Seiki M and Okada Y. (1999). Am. J. Pathol., 154, 417-428.
37. Nakajima M, Welch DR, Wynn DM, Tsuruo T and Nicolson GL. (1993). Cancer Res., 53, 5802-5807.
38. Parks RJ and Bramson JL. (1999). Gene Ther., 6, 1349-1350.
39. Price A, Shi Q, Morris D, Wilcox ME, Brasher PM, Rewcastle NB, Shalinsky D, Zou H, Appelt K, Johnston RN, Yong VW, Edwards D and Forsyth P. (1999). Clin. Cancer Res., 5, 845-854.
40. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA and Sawaya R. (1993). Cancer Res., 53, 2208-2211.
41. Rao JS, Yamamoto M, Mohaman S, Gokaslan ZL, Fuller GN, Stetler-Stevenson WG, Rao VH, Liotta LA, Nicolson GL and Sawaya RE. (1996). Clin. Exp. Metast., 14, 12-18.
42. Rasmussen HS and McCann PP. (1997). Pharmacol. Ther., 75, 69-75.
43. Sato H and Seiki M. (1993). Oncogene, 8, 395-405.
44. Scatena R. (2000). Expert. Opin. Investig. Drugs, 9, 2159-2165.
45. Seiki M. (1999). APMIS, 107, 137-143.
46. Shalinsky DR, Brekken J, Zou H, McDermott CD, Forsyth P, Edwards D, Margosiak S, Bender S, Truitt G, Wood A, Varki NM and Appelt K. (1999). Ann. NY Acad. Sci., 878, 236-270.
47. Shingleton WD, Hodges DJ, Brick P and Cawston TE. (1996). Biochem. Cell. Biol., 74, 759-775.
48. Stetler-Stevenson WG, Aznavoorian S and Liotta LA. (1993). Annu. Rev. Cell. Biol., 9, 541-573.
49. Tonn JC, Kerkau S, Hanke A, Bouterfa H, Mueller JG, Wagner S, Vince GH and Roosen K. (1999). Int. J. Cancer, 80, 764-772.
50. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM and Werb Z. (1998). Cell, 93, 411-422.
51. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA and Goldberg GI. (1989). J. Biol. Chem., 264, 17213-17221.
52. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Saro H, Gokaslan ZL, Liotta LA, Nicolson GL and Rao JS. (1996). Cancer Res., 56, 384-392.
53. Yip D, Ahmad A, Karapetis CS, Hawkins CA and Harper PG. (1999). Invest. New Drugs, 17, 387-399.